The innovative technology was developed by Gameto. It has led to the world's first human live birth using stem cells to mature embryos outside the body. This new approach promises to be faster, safer and more affordable than traditional in vitro fertilization (IVF). Unlike IVF, where mature eggs are retrieved from the ovaries and fertilized in the lab, Fertilo uses supporting ovarian cells derived from induced pluripotent stem cells (iPSCs). This method significantly reduces the number of hormone injections required - up to 80% - and reduces the treatment cycle to 3 days. With the new technology, Gameto hopes to improve women's reproductive health and make the process of conception more accessible to anyone wishing to become a parent. The technology has already received regulatory approval in Australia, Japan, Argentina, Paraguay, Mexico and Peru. The company plans to begin trials in the United States in the near future